Patent · US Expired

Recombinant allergen with reduced enzymatic activity

US7348009B1 · kind B1 · utility

0Cited by

2References

4Claims

0Family size

Assignee

SmithKline Beecham Biologicals S.A. · BE

Inventors

Claudine Bruck · Rixensart, BE
Alex Bollen · Itterbeek, BE
Paul Jacobs · Lanquesaint, BE
Marc Georges Francis Massaer · Brussels, BE

Key dates

Filing date	Nov 16, 1998
Grant date	Mar 25, 2008
Priority date	—
Expiry date	Nov 16, 2018

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N9/6472
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention provides a novel treatment for allergy comprising a recombinant allergen with reduced enzymatic activity, thereby reducing the potential for an allergic response upon contact with a wild-type allergen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.